Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2006
07/05/2006CN1795843A Control release system for medication in zero order
07/05/2006CN1795838A Cotton bar, cotton bar type suppository and preparing technique
07/05/2006CN1262556C Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent
07/05/2006CN1262456C Method and device for producing thin wafers from a film of active ingredients
07/05/2006CN1262311C Medicinal composition for target direction transport curing cancer and its usage
07/05/2006CN1262308C Use of enzymes obtained from ciliates as medicaments for promoting digestion
07/05/2006CN1262301C Medicine for drug rehabilitation
07/05/2006CN1262299C Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method
07/05/2006CN1262298C Externally applied medicine for treating hyperosteogeny and preparation method thereof
07/05/2006CN1262297C Chinese medicine for treating irritable bowel syndrome and preparing method thereof
07/05/2006CN1262295C Health care medicine capable of strengthening heart and kidney function and immunologic function
07/05/2006CN1262294C Ginseng and aconite injection liquid for treating qi vacuity and yang desertion and its preparation method
07/05/2006CN1262293C Ginseng and aconite preparation for treating qi vacuity yang desertion and its extraction method
07/05/2006CN1262289C Application of antimonocytic activity of extracts of piper betel leaves
07/05/2006CN1262288C Preparing method of licorice extracturm by means of producing refuse with glycyrrhizin
07/05/2006CN1262285C Liniment for skin and its preparation
07/05/2006CN1262278C Antiacid and laxative tablets
07/05/2006CN1262277C Injection of low molecular weight chondroitin sulfate and its preparation method
07/05/2006CN1262275C Anticancer
07/05/2006CN1262270C Application of levocarnitine and its derivative in preventing and treating high altitude diseases
07/05/2006CN1262213C Water containing soluble fiber
07/04/2006US7071233 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex.
07/04/2006US7071214 Compounds and compositions for delivering active agents
07/04/2006US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives
07/04/2006US7071203 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon
07/04/2006US7070828 Process for coating solid particles
07/04/2006US7070825 Infant formula
07/04/2006US7070817 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
07/04/2006US7070812 Process for producing dry powders of one or more carotenoids
07/04/2006US7070811 Directly compressible formulations of azithromycin
07/04/2006US7070810 Use of buckysome or carbon nanotube for drug delivery
07/04/2006US7070809 Hydrogel biomedical articles
07/04/2006US7070808 Comprising an adhesive, drug in protonated form, a nonaqueous solvent capable of dissolving nonprotonated and protonated forms of the drug, and a biocompatible deprotonating agent to deprotonate the drug without irritating the skin
07/04/2006US7070807 Administering polypeptide by injection; gene therapy
07/04/2006US7070806 Controlled release formulations coated with aqueous dispersions of acrylic polymers
07/04/2006US7070805 Comprises a pharmacologically active ingredient, a sugar and a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropyl group; fast disintegrability, suitable strength and no roughness
07/04/2006US7070804 Vitamin tablet enhancing appetite and calcium absorption
07/04/2006US7070803 Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine
07/04/2006US7070802 a cyclosporin and a carrier medium comprising a polyethylene glycol glyceryl fatty acid ester, a monoglyceride, diglyceride, and/or medium-chain triglyceride, and a surfactant for oral administration; forms a clear, fine emulsion when contacted with water
07/04/2006US7070801 Drug delivery system
07/04/2006US7070800 Inhalable powder containing tiotropium
07/04/2006US7070799 Method for administering insulin to the buccal region
07/04/2006US7070798 Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
07/04/2006US7070796 Pharmaceutically stable oxaliplatinum preparation for parenteral administration
07/04/2006US7070766 Delivery of physiologically active compounds through an inhalation route
07/04/2006US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns.
07/04/2006US7070764 Delivery of analgesics through an inhalation route
07/04/2006US7070763 Delivery of diphenhydramine through an inhalation route
07/04/2006US7070762 Delivery of analgesics through an inhalation route
07/04/2006US7070761 Aerosols; heating, vaporization, cooling
07/04/2006US7070722 for medical or veterinary use; gelling agent treated with a first precipitant which is calcium citrate and/or calcium-releasing water-soluble glass to stabilize the gelling agent; foaming and curing; immersing foam in a second calcium precipitant; sterlizing with gamma radiation or ethylene oxide
07/04/2006US7070656 Electrostatic coating
07/04/2006US7070605 Great saphenous vein varix treatment tool
07/04/2006US7070592 Medical device with array of electrode-containing reservoirs
07/04/2006US7070591 Vascular access port with physiological sensor
07/04/2006US7070590 Microchip drug delivery devices
07/04/2006CA2462452C Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
07/04/2006CA2414945C Cellulose powder
07/04/2006CA2267091C Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method
07/04/2006CA2247329C Composition containing antitumor agent
07/04/2006CA2159419C Solid pharmaceutical composition comprising an excipient capable of binding water
06/2006
06/29/2006WO2006069344A2 Controlled release hydrogels
06/29/2006WO2006069240A2 Composition and treatment methods for coronary artery disease
06/29/2006WO2006069213A1 Pharmaceutical formulations
06/29/2006WO2006069098A1 Nanoparticulate bicalutamide formulations
06/29/2006WO2006069079A2 Methods and formulations
06/29/2006WO2006069038A1 Therapeutic materials and methods
06/29/2006WO2006069030A1 Pharmaceutical compositions for sleep disorders
06/29/2006WO2006068921A2 Device for ophthalmic drug delivery
06/29/2006WO2006068899A2 Preserved ophthalmic compositions comprising aloe vera
06/29/2006WO2006068898A1 Reusable drug delivery device
06/29/2006WO2006068890A2 Lipid particles comprising bioactive agents, methods of preparing and uses thereof
06/29/2006WO2006068877A2 Sustained-release nanoparticle compositions and methods for using the same
06/29/2006WO2006068759A2 Liposomes containing phytochemical agents and methods for making and using same
06/29/2006WO2006068715A2 Cosmetic compositions having carnitine creatinate and methods for using
06/29/2006WO2006068596A1 Solid dosage form comprising proton pump inhibitor and suspension made thereof
06/29/2006WO2006068266A1 PROSTAGLANDIN F2α DERIVATIVE CONTAINING PRODUCTS
06/29/2006WO2006068232A1 Drug carrier and drug carrier kit for inhibiting fibrosis
06/29/2006WO2006068166A1 Dry granulated substance and process for producing the same
06/29/2006WO2006068105A1 Therapeutic agent for keratoconjunctive disorder
06/29/2006WO2006067605A1 Stable pharmaceutical compositions of tiagabine and processes for their preparation
06/29/2006WO2006067601A1 Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation
06/29/2006WO2006067600A2 Herbal formulations as cough lozenge
06/29/2006WO2006067599A2 Stable oral benzimidazole compositions and process of preparation thereof
06/29/2006WO2006067593A1 Orally disintegrating pharmaceutical compositions with sensory cue agents
06/29/2006WO2006067576A1 Enteric coated azithromycin multiparticulates
06/29/2006WO2006067514A1 Multilayered dosing systems
06/29/2006WO2006067502A1 Treatment of inflammatory diseases
06/29/2006WO2006066961A1 Solid pharmaceutical composition comprising valsartan
06/29/2006WO2006066949A1 Compositions comprising an epothilone and production methods
06/29/2006WO2006066932A1 Stable pharmaceutical composition comprising an active substance in the form of solid solution
06/29/2006WO2006066930A1 Stable pharmaceutical composition comprising amoxicillin and clavulanic acid
06/29/2006WO2006066907A1 Pharmaceutical formulations
06/29/2006WO2006066870A1 Solid pharmaceutical compositions
06/29/2006WO2006066868A2 Sustained release formulation comprising bisphosphonate
06/29/2006WO2006066788A1 Transdermal plaster with progesterone a-specific ligands (prasl) as an active ingredient
06/29/2006WO2006066780A1 Combinations of valategrast and montelukast for treating asthma
06/29/2006WO2006066509A1 Injectable sustained release microspheric preparation of 3,3-diphenylpropylamine derivatives as muscarinic receptor antagonists
06/29/2006WO2006066500A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease
06/29/2006WO2006066399A1 Tablet formulation for sustained drug-release